IXICO
Intelligent Insights in Neuroscience

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.
For Tasks:
Click tags to check more tools for each tasksFor Jobs:
Features
- Advanced analytics and AI technology
- Innovative imaging biomarkers
- Secure data platforms for clinical trials
- Expert radiological reads and analysis
- Customized TrialTracker platform
Advantages
- Specialist focus on neurological disorders
- Global network of imaging centers
- Highly reliable and regulatory compliant data
- Expertise in CNS therapeutics
- Accurate measurement of brain biomarkers
Disadvantages
- May require specialized training to fully utilize the AI technology
- Dependence on imaging centers for data collection
- Complex data management workflows
Frequently Asked Questions
-
Q:What services does IXICO offer?
A:IXICO offers services in drug development analytics, imaging operations, and post-marketing consultancy. -
Q:What are the advantages of using IXICO's technology?
A:Advantages include expert radiological reads, innovative imaging biomarkers, and secure data platforms. -
Q:How does IXICO support biopharmaceutical companies?
A:IXICO supports companies in CNS clinical research with intelligent insights and cutting-edge neuroimaging techniques.
Alternative AI tools for IXICO
Similar sites

IXICO
IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Genie TechBio
Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

Insight
Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

neurons.bio
neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Exscientia
Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Owkin
Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Google Research
Google Research is a leading research organization focusing on advancing science and artificial intelligence. They conduct research in various domains such as AI/ML foundations, responsible human-centric technology, science & societal impact, computing paradigms, and algorithms & optimization. Google Research aims to create an environment for diverse research across different time scales and levels of risk, driving advancements in computer science through fundamental and applied research. They publish hundreds of research papers annually, collaborate with the academic community, and work on projects that impact technology used by billions of people worldwide.

OpenLife.ai
The website OpenLife.ai is an AI tool that focuses on various aspects of healthcare, including medical AI, ambient clinical intelligence, clinical documentation integrity, healthcare analytics, patient engagement, radiology solutions, and more. It offers insights, news, and resources related to the application of artificial intelligence in the healthcare industry.

iCAD
iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

Tempus
Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Insitro
Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

MeDA School
MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

EleutherAI
EleutherAI is an open-source AI research platform that focuses on discussing and disseminating cutting-edge research in the field of artificial intelligence. The platform provides updates on various research projects, including Mechanistic Anomaly Detection, Automated Interpretability for Sparse Autoencoder Features, Experiments in Generalization, Concept Erasure, Knowledge Elicitation, and more. EleutherAI aims to foster collaboration and innovation in the AI community by sharing insights and advancements in the field.

Tempus
Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

iLovePhD
iLovePhD is a comprehensive research platform that serves as a one-stop solution for all research needs. It offers a wide range of services including access to journals, postdoc opportunities, scholarships, IoT security tools, job listings, datasets, and UGC-CARE journals. The platform also features ChatGPT for plagiarism detection and artificial intelligence applications. iLovePhD aims to assist researchers and academicians in publishing impactful work and staying updated with the latest trends in the academic world.

CCDS
CCDS (Center for Computational & Data Sciences) is a research center at Independent University Bangladesh dedicated to artificial intelligence, data sciences, and computational science. The center has various wings focusing on AI, computational biology, physics, data science, human-computer interaction, and industry partnerships. CCDS explores the use of computation to understand nature and society, uncover hidden stories in data, and tackle complex challenges. The center collaborates with institutions like CERN and the Dunlap Institute for Astronomy and Astrophysics.
For similar tasks

IXICO
IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Biofourmis
Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure
AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Recursion
Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.
For similar jobs

IXICO
IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

RejuveAI
RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology to analyze human body functions in-depth, providing insights for aging combat. RejuveAI collaborates with researchers, clinics, and data enthusiasts to ensure innovative outcomes are affordable and accessible. The platform also offers exclusive discounts on travel, supplements, medical tests, and longevity therapies.

NeuProScan
NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight
Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis
Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure
AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT
CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome
Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai
Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI
Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio
neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Ignota Labs
Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Trially AI
Trially AI is a HIPAA-compliant AI clinical trial platform that leverages advanced technology to help life science leaders enroll qualified patients faster. The platform uses AI algorithms to unlock rich medical data, match patients to trials, and improve enrollment rates. Trially AI is proven to deliver superior results 4x faster than other technology providers, with features like multiplying enrollment, reducing screen fails, and increasing eligibility accuracy. It benefits sponsors, CROs, research sites, and hospitals by improving enrollment rates, saving time on chart reviews, and enhancing site success outcomes.

Steven Thompson AI HealthTech Leader
Steven Thompson is an AI HealthTech Leader specializing in Trial Orchestration. He builds systems that simplify complexity and lead teams to success, from large ERP programs to AI orchestration in clinical trials. The website showcases his expertise in compliance, scale, and human resilience, offering insights, case studies, and speaking engagements related to AI, trials, and ERP. Steven's approach emphasizes audit readiness, human-in-loop AI, and a focus on finishing strong. The site serves as a platform for industry leaders seeking transformation and measurable outcomes in their projects.

MeDA School
MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.